BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 34042995)

  • 21. Autologous followed by allogeneic versus tandem-autologous transplantation in high-risk, newly diagnosed multiple myeloma: a systematic review and meta-analysis.
    Wei M; Xie C; Huang J; Liu Q; Lai Y
    Hematology; 2023 Dec; 28(1):2269509. PubMed ID: 37850613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Allogeneic hematopoietic stem cell transplantation in T-cell lymphoma: a Meta-Analysis.
    Singh V; Kim S; Deol A; Uberti JP; Modi D
    Leuk Lymphoma; 2022 Apr; 63(4):855-864. PubMed ID: 34866528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of Autologous and Allogeneic Hematopoietic Cell Transplantation in Waldenström Macroglobulinemia: A Systematic Review and Meta-analysis.
    Parrondo RD; Reljic T; Iqbal M; Ayala E; Tun HW; Kharfan-Dabaja MA; Kumar A; Murthy HS
    Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):e694-e711. PubMed ID: 32616401
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Controversies in autologous and allogeneic hematopoietic cell transplantation in peripheral T/NK-cell lymphomas.
    Shustov A
    Best Pract Res Clin Haematol; 2013 Mar; 26(1):89-99. PubMed ID: 23768643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparative study on allogeneic with autologous hematopoietic stem cell transplantation in adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia in the era of TKIs: a systematic review and meta-analysis.
    Wei H; Kuang P; Liu T
    Ann Hematol; 2020 Nov; 99(11):2619-2628. PubMed ID: 32960314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A retrospective analysis of peripheral T-cell lymphoma treated with the intention to transplant in the first remission.
    Mehta N; Maragulia JC; Moskowitz A; Hamlin PA; Lunning MA; Moskowitz CH; Zelenetz A; Matasar MJ; Sauter C; Goldberg J; Horwitz SM
    Clin Lymphoma Myeloma Leuk; 2013 Dec; 13(6):664-70. PubMed ID: 24035712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation.
    Huang WR; Liu DH
    Chin Med J (Engl); 2018 Sep; 131(17):2105-2111. PubMed ID: 30127221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Meta-analysis on the efficacy of allogeneic hematopoietic stem cell transplantation to treat malignant lymphoma.
    Zhao J; Guo X; Zheng M; Su L
    Open Life Sci; 2024; 19(1):20220771. PubMed ID: 38840889
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allogeneic hematopoietic stem cell transplantation for B-cell lymphoma in Taiwan.
    Lee CH; Lin TC; Yao M; Hsiao LT; Ko BS; Liu CJ; Chen TY
    Cancer Med; 2023 Dec; 12(24):21761-21769. PubMed ID: 38018321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allogeneic hematopoietic stem cell transplantation for relapsed follicular lymphoma: A combined analysis on behalf of the Lymphoma Working Party of the EBMT and the Lymphoma Committee of the CIBMTR.
    Sureda A; Zhang MJ; Dreger P; Carreras J; Fenske T; Finel H; Schouten H; Montoto S; Robinson S; Smith SM; Boumedil A; Hamadani M; Pasquini MC
    Cancer; 2018 Apr; 124(8):1733-1742. PubMed ID: 29424927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upfront allogeneic stem-cell transplantation for patients with nonlocalized untreated peripheral T-cell lymphoma: an intention-to-treat analysis from a single center.
    Loirat M; Chevallier P; Leux C; Moreau A; Bossard C; Guillaume T; Gastinne T; Delaunay J; Blin N; Mahé B; Dubruille V; Augeul-Meunier K; Peterlin P; Maisonneuve H; Moreau P; Juge-Morineau N; Jardel H; Mohty M; Moreau P; Le Gouill S
    Ann Oncol; 2015 Feb; 26(2):386-92. PubMed ID: 25392158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of peripheral T-cell lymphomas (PTCL) with high-dose chemotherapy and autologous or allogeneic hematopoietic transplantation.
    Kahl C; Leithäuser M; Wolff D; Steiner B; Hartung G; Casper J; Freund M
    Ann Hematol; 2002 Nov; 81(11):646-50. PubMed ID: 12454703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of hematopoietic stem cell transplantation for relapsed and refractory Hodgkin lymphoma.
    Kako S; Izutsu K; Kato K; Kim SW; Mori T; Fukuda T; Kobayashi N; Taji H; Hashimoto H; Kondo T; Sakamaki H; Morishima Y; Kato K; Suzuki R; Suzumiya J;
    Am J Hematol; 2015 Feb; 90(2):132-8. PubMed ID: 25382792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allogeneic stem cell transplantation using lymphoablative rather than myeloablative conditioning regimen for relapsed or refractory lymphomas.
    Yoon JH; Jeon YW; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Cho SG
    Hematol Oncol; 2017 Mar; 35(1):17-24. PubMed ID: 25782369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of autologous hematopoietic stem cell transplantation for peripheral T-cell lymphoma: pre-transplant patients with partial remission benefit from post-transplant maintenance therapy.
    Huang Z; Li Z; Wang J; Gui R; Zu Y; Yu F; Lin Q; Zhao H; Zhang Y; Fang B; Liu Y; Zhou K; Li Y; Fu Y; Yao Z; Song Y; Zhou J
    Front Oncol; 2023; 13():1162413. PubMed ID: 37256185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficiency of autologous stem cell transplantation as the first-line treatment for nodal peripheral T-cell lymphoma: results of a systematic review and meta-analysis.
    Zhai Y; Wang J; Jiang Y; Wu W; Lv Y; Xu H; Tian L; Sun H; Zhao Z; Li L
    Expert Rev Hematol; 2022 Mar; 15(3):265-272. PubMed ID: 35152814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis.
    Berning P; Schmitz N; Ngoya M; Finel H; Boumendil A; Wang F; Huang XJ; Hermine O; Philippe L; Couronné L; Jaccard A; Liu D; Wu D; Reinhardt HC; Chalandon Y; Wagner-Drouet E; Kwon M; Zhang X; Carpenter B; Yakoub-Agha I; Wulf G; López-Jiménez J; Sanz J; Labussière-Wallet H; Shimoni A; Dreger P; Sureda A; Kim WS; Glass B
    Leukemia; 2023 Jul; 37(7):1511-1520. PubMed ID: 37157017
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-myeloablative allogeneic hematopoietic stem cell transplantation for adults with relapsed and refractory mantle cell lymphoma: a single-center analysis in the rituximab era.
    Mussetti A; Devlin SM; Castro-Malaspina HR; Barker JN; Giralt SA; Zelenetz AD; Sauter CS; Perales MA
    Bone Marrow Transplant; 2015 Oct; 50(10):1293-1298. PubMed ID: 26146802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic stem-cell transplantation for peripheral T-cell lymphoma: a systemic review and meta-analysis.
    Wei J; Xu J; Cao Y; Zhou J; Zhang Y
    Acta Haematol; 2015; 133(2):136-44. PubMed ID: 25247746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [A comparative study of induction chemotherapy with or without autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed young medium/high risk diffuse large B cell lymphoma patients].
    Wang X; Xia B; Wang CY; Li MZ; Xu W; Yuan T; Tian C; Zhao HF; Yang HL; Zhao ZG; Wang XF; Wang YF; Yu Y; Zhang YZ
    Zhonghua Xue Ye Xue Za Zhi; 2019 Feb; 40(2):117-124. PubMed ID: 30831626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.